ROBERT NELSEN - 22 Jun 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Signature
By: Robert Nelsen, Managing Director, By: /s/ Mark McDonnell, as Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
22 Jun 2021
Net transactions value
$0
Form type
4
Filing time
24 Jun 2021, 17:05:32 UTC
Previous filing
23 Jun 2021
Next filing
06 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 -435,562 -3.8% $0.000000 11,179,423 22 Jun 2021 See footnote F1, F2
transaction VIR Common Stock Other $0 -564,438 -3.8% $0.000000 14,487,240 22 Jun 2021 See footnote F1, F3
transaction VIR Common Stock Other $0 +11,974 +50% $0.000000 35,928 22 Jun 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of Common Stock held by a limited partnership to its partners for no consideration.
F2 The shares are held by ARCH Venture Fund IX, L.P. ("ARCH IX"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX, L.P., which is the sole general partner of ARCH IX, and shares voting and investment control with respect to shares held by ARCH IX. The Reporting Person may be deemed to beneficially own the shares held by ARCH IX, and the Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
F3 The shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), which is the sole general partner of ARCH Overage, and shares voting and investment control with respect to shares held by ARCH Overage. The Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
F4 Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.